This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Industry Veteran Bill Vaughan Joins Remedi SeniorCare® To Elevate Education And Consulting Throughout The LTC Industry

BALTIMORE, April 25, 2013 /PRNewswire/ -- Remedi SeniorCare ® has named Bill Vaughan as the new Vice President of Education and Clinical Affairs. In this new role, Vaughan will serve as a key clinical resource for Remedi customers, partners and industry professionals. He will work to further Remedi's footprint throughout the industry, contributing thought leadership through educational and consulting engagements at key venues, Remedi pharmacies and in the media.

(Logo:  http://photos.prnewswire.com/prnh/20130425/PH02001LOGO )

"Bill has been an important part of the Maryland healthcare community for over 30 years," said Michael Bronfein, Remedi's Chairman and CEO. "Our customers, our colleagues and our industry look to his unparalleled experience as a state LTC surveyor and the Chief Nurse of Maryland's Office of Health Care Quality. We are very pleased and very fortunate to have him join the Remedi team and look forward to his leadership and deep expertise in clinical practices and regulations."

Vaughan's area of focus will include the promotion of Remedi's innovative, leading-edge pharmacy solutions – including Paxit ® automated medication dispensing – in conjunction with industry best practices to address the complex clinical and regulatory challenges in long-term care. He will also work with Remedi customers and partners to improve the regulatory oversight of healthcare facilities and advance person-centered care across the board.

Mr. Vaughan recently retired after a 25 year career with Maryland's regulatory agency, the Office of Health Care Quality. After spending 14 years as a Health Facility Surveyor, he was promoted to Chief Nurse of the Office in 2001. In this position, he provided clinical guidance and oversight to the agency's 120 surveyors. Prior to his work with the state, Vaughan held various leadership roles in nursing. He received his Bachelor of Science in Nursing at the University of Maryland at Baltimore.

About Remedi SeniorCare

Remedi SeniorCare ®, a leading-edge pharmacy provider, enables long-term care facilities to deliver better business results and provide exceptional resident-centered care. At the forefront of implementing high-tech advancements for the industry, Remedi redefined medication administration and management with the launch of the Paxit ® automated medication dispensing system, delivering superior accuracy, efficiency and medication cost reduction.  Remedi's online and electronic tools via My Remedi ® web portal and Connexit electronic data interchange further drive business management efficiency and overall cost reduction.  Remedi supports more than 30,000 residents across nine states and Washington, D.C. with RapidResponse SM customer service, ensuring prompt access to medication delivery, expertise and comprehensive support. For more information, visit www.RemediRx.com.

SOURCE Remedi SeniorCare

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,288.63 +155.93 0.86%
S&P 500 2,117.39 +12.89 0.61%
NASDAQ 5,008.0960 +44.5690 0.90%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs